EQUITY INCENTIVE PLAN, Summary (Details) - USD ($)		3 Months Ended		12 Months Ended
	Jun. 25, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Jun. 18, 2019	Jun. 19, 2014
Stock Compensation Expense [Abstract]
Allocated share-based compensation expense		$ 750,903	$ 579,789
Stock Options, Additional Disclosure [Abstract]
Outstanding, aggregate intrinsic value, end of period		0
Exercisable, aggregate intrinsic value, end of period		0
Cost of Product Sales [Member]
Stock Compensation Expense [Abstract]
Allocated share-based compensation expense		54,250	28,768
Research and Development Expenses [Member]
Stock Compensation Expense [Abstract]
Allocated share-based compensation expense		91,189	90,920
Selling, General and Administrative Expenses [Member]
Stock Compensation Expense [Abstract]
Allocated share-based compensation expense		$ 605,464	$ 460,101
Stock Options [Member]
Assumptions Made in Calculating Fair Values of Options [Abstract]
Expected term		6 years
Expected volatility		91.40%
Expected dividend yield
Risk-free interest rate		1.91%
Stock Options, Number of Shares [Roll forward]
Outstanding, beginning of period (in shares)		1,600,372
Granted (in shares)		2,358,539
Exercised (in shares)		0
Forfeited (in shares)		14,883
Expired (in shares)		183,241
Outstanding, end of period (in shares)		3,760,787		1,600,372
Exercisable, end of period (in shares)		565,215
Stock Options, Weighted Average Exercise Price per Share [Roll Forward]
Outstanding, beginning of period (in dollars per share)		$ 4.18
Granted (in dollars per share)		1.23
Exercised (in dollars per share)		0
Forfeited (in dollars per share)		2.42
Expired (in dollars per share)		5.63
Outstanding, end of period (in dollars per share)		2.27		$ 4.18
Exercisable, end of period (in dollars per share)		$ 3.68
Stock Options, Additional Disclosure [Abstract]
Outstanding, weighted average remaining contract term		8 years 7 months 24 days		6 years 7 months 2 days
Exercisable, weighted average remaining contract term		5 years 10 months 20 days
Outstanding, aggregate intrinsic value, beginning of period		$ 0
Granted, aggregate intrinsic value		0
Exercised, aggregate intrinsic value		0
Forfeited, aggregate intrinsic value		0
Outstanding, aggregate intrinsic value, end of period		0		$ 0
Exercisable, aggregate intrinsic value, end of period		$ 0
2014 Stock Incentive Plan [Member] | Stock Options [Member]
Share-based Arrangements with Employees and Nonemployees [Abstract]
Number of shares authorized under the plan (in shares)						800,000
Number of stock options expired, forfeited or exercised under the plan (in shares)		732,064
Options still available to be issued (in shares)		0
Stock Options, Number of Shares [Roll forward]
Outstanding, end of period (in shares)		46,875
2019 Omnibus Incentive Plan [Member] | Stock Options [Member]
Share-based Arrangements with Employees and Nonemployees [Abstract]
Number of shares authorized under the plan (in shares)	4,800,000				2,400,000
Increase in number of shares authorized (in shares)	2,400,000
Number of stock options expired, forfeited or exercised under the plan (in shares)		866,709
Options still available to be issued (in shares)		83,234
Stock Options, Number of Shares [Roll forward]
Outstanding, end of period (in shares)		4,915,279
2014 & 2019 Stock Incentive Plan [Member] | Stock Options [Member]
Stock Options, Number of Shares [Roll forward]
Outstanding, end of period (in shares)		21,061